Analysis of CCR2 chemokine receptor gene polymorphism in patients with bronchial asthma and chronic obstructive pulmonary disease

Черкашина, И. И.; Никулина, С. Ю.; Логвиненко, Н. И.; Шульман, В. А.; Шестовицкий, В. А.; Воевода, М. И.; Максимов, В. Н.; Чернова, А. А.

doi:10.18093/0869-0189-2013-0-1-20-24

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some polymorphic markers of candidate genes may contribute to the development of airway obstruction due to loss of lung elasticity, while others contribute to chronic inflammation leading to airway obstruction or poor response to medications such as β2-agonists or (iGCS) [7].…”

Section: Introductionmentioning

confidence: 99%

Association of Polymorphic Variants of HHIP, ADRB2 and IL-33 Genes with Clinical Manifestations of Bronchial Asthma in Children

Alieva,

Furman,

Kondratyeva

et al. 2023

Preprint

View full text Add to dashboard Cite

Studying the contribution of genetic mechanisms to the development of bronchial asthma (BA) is to look for associations of the disease and its phenotypes with polymorphic markers of candidate genes.ObjectiveTo investigate the association of polymorphic variants of HHIP, ADRB2 and IL-33 genes with the phenotypes of clinical course of BA in children and the effectiveness of therapy of the diseasePatients and methodsA cohort single-center study of 90 bronchial asthma patients aged 5 to 17 years with an established diagnosis of bronchial asthma of varying degree of severity and control was conducted. The allele and genotype frequencies of polymorphic loci of the following genes were studied: rs12551256-A and rs146597587-G of IL-33 gene; rs12504628 of HHIP gene and ARG16GLY rs1042713 of ADRB2 gene in 90 BA patients with regard to the severity and control of the disease. In children with severe BA, as well as in children with poorly controlled/uncontrolled asthma (n=26), sequencing of the entire coding sequence of the IL-33 gene located on the 9th chromosome in the 9p24.1 region was additionally performed (search for mutations in 9 exons).ResultsComparison of genetic markers in patients with severe BA (tBA) and non-severe BA (nBA) revealed a reduced risk of severe disease realization among those carrying the TT genotype (OR=0.221 (95% CI: 0.059-0.828; χ2=5.759; p=0.056)) and the T allele (OR=0.491 (95% CI: 0.190-1.269; χ2=4.270; p=0.039)) of the studied genetic variant rs12504628 (T>C) of the HHIP gene, the frequency of the CC genotype in severe BA was 64%, versus 28% in nonsevere BA, and the C allele 77% versus 52%.Comparison of genetic markers in patients with a combination of atopic dermatitis (AtD) and bronchial asthma (BA+AtD) and BA without AtD (BA without AtD) revealed an increased risk of combining asthma and dermatitis among individuals carrying the TT genotype (OR=2.875 (95% CI: 1.130-7.316; χ2=5.751; p=0.056)) of genetic variant rs12504628 (T>C) of the HHIP gene. Sequencing and exome analysis of the IL-33 gene showed a statistically significant positive association between the frequency of lesions in exons 4 (r=0.417; p=0.034) and 6 (r=0.593; p=0.001) on the one hand and the severity of BA on the other. Nucleotide substitutions in these exons were found to be more frequently associated with the severe course of bronchial asthma.ConclusionIt was shown that TT genotype of genetic variant rs12504628 (T>C) of HHIP gene reduces the risk of severe BA, but increases the risk of atopic dermatitis combined with BA by 2.8 times. The CC+ST genotype of the HHIP gene increases the risk of drug allergy against the background of BA by 2.9 times. Polymorphic variants in exons 4 and 6 of the IL-33 gene are more often combined with moderate and severe asthma, and nucleotide substitutions in exons 4 and 6 are associated with a severe course of BA.

show abstract

Section: Introductionmentioning

confidence: 99%